Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600127852Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in Procedural anxiety (2 arms), sponsored by Jinjiang Municipal Hospital. Primary endpoint: Incidence of hypotension. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600127852.